Structure of a trial. by Marcel F. Hinss (14675457)

Subjects:

Graph of surface roughness values of specimens after testing with different particle sizes at a concentration of 0.4 mg/mL (a) Ra, Rq (b) Rz (c) Sa, Sq (d) Sz, Sp, Sv. by Yang Li (7082)

Subjects:

Graph of surface roughness values of specimens after testing with different particle sizes at a concentration of 4 mg/mL (a) Ra, Rq (b) Rz (c) Sa, Sq (d) Sz, Sp, Sv. by Yang Li (7082)

Subjects:

Evolution of sportspersonship in the different categories of the FRM schools and the association football clubs. by Gema Ortega Vila (19870900)

Subjects:

RT (in ms, bars) and ACC (in %, line) for the effect of congruency task convergence, with 95% confidence interval. by Marcel F. Hinss (14675457)

Subjects:

Particle size distribution chart of 10-micron iron oxide particles. by Yang Li (7082)

Subjects:

Effect of the type of switch trial on performance. by Marcel F. Hinss (14675457)

Subjects:

Evolution of personal factors in the different categories in the FRM social sports schools and in the association football clubs. by Gema Ortega Vila (19870900)

Subjects:

Graph of temperature rise variation for test groups with different particle sizes at two concentrations. by Yang Li (7082)

Subjects:

Parameter diagram for pit features on the specimen surface (a) Volume (b) Surface Area (c) Depth (d) Cross-sectional area. by Yang Li (7082)

Subjects:

Significant age effects on model parameters extracted from the winning model M7. by Vanessa Scholz (20208617)

Analysis of attributable risk factors for Disability-Adjusted Life Years. by Lixia Lin (478155)

Subjects:

Logistic regression of independent variables which showed a statistically significant association with medication adherence status. by Israel Abebrese Sefah (9991841)

Results for Obesity at 42 years old for individuals healthy/underweight at 16 years old (n = 4767, 27.192% of N). by Glenna Nightingale (4806495)

Subjects:

Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

Subjects:

Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

Subjects:

Subgroup Analysis of the Occurrence of Secondary Endpoints. by Karl Ingard (22582091)

Subjects:

Study flow chart. by Karl Ingard (22582091)

Subjects:

Kaplan-Meier curve of the primary outcome. by Karl Ingard (22582091)

Subjects:

Number of Patients Who Reached the Primary and Secondary Endpoints During Follow-up. by Karl Ingard (22582091)

Subjects: